SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial

SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial

Abstract Background Sarpogrelate is expected to reduce restenosis by protecting blood vessels from oxidative stress and vascular endothelial dysfunction as well as by acting as an antiplatelet agent after endovascular treatment (EVT). This trial was designed to compare aspirin plus sustained-release...

Full description

Bibliographic Details
Main Authors: Sanghyun Ahn, Joongyub Lee, Seung-Kee Min, Jongwon Ha, Sang-il Min, Song-Yi Kim, Min-Ji Cho, Sungsin Cho, SAFE study investigators
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Trials
Subjects:
Endovascular treatment
Sarpogrelate
Peripheral artery disease
Stenosis
Femoro-popliteal
Online Access:http://link.springer.com/article/10.1186/s13063-017-2155-5

Internet

http://link.springer.com/article/10.1186/s13063-017-2155-5

Similar Items